Matches in Wikidata for { <http://www.wikidata.org/entity/Q91895948> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91895948 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91895948 description "scientific article published on 14 April 2020" @default.
- Q91895948 description "wetenschappelijk artikel" @default.
- Q91895948 description "наукова стаття, опублікована 14 квітня 2020" @default.
- Q91895948 name "Preclinical evaluation of a high affinity sarcophagine-containing PSMA ligand for 64Cu/67Cu-based theranostics in prostate cancer" @default.
- Q91895948 name "Preclinical evaluation of a high affinity sarcophagine-containing PSMA ligand for 64Cu/67Cu-based theranostics in prostate cancer" @default.
- Q91895948 type Item @default.
- Q91895948 label "Preclinical evaluation of a high affinity sarcophagine-containing PSMA ligand for 64Cu/67Cu-based theranostics in prostate cancer" @default.
- Q91895948 label "Preclinical evaluation of a high affinity sarcophagine-containing PSMA ligand for 64Cu/67Cu-based theranostics in prostate cancer" @default.
- Q91895948 prefLabel "Preclinical evaluation of a high affinity sarcophagine-containing PSMA ligand for 64Cu/67Cu-based theranostics in prostate cancer" @default.
- Q91895948 prefLabel "Preclinical evaluation of a high affinity sarcophagine-containing PSMA ligand for 64Cu/67Cu-based theranostics in prostate cancer" @default.
- Q91895948 P1433 Q91895948-CD13E7C8-4EDB-494E-8517-DD9D3D6B83A9 @default.
- Q91895948 P1476 Q91895948-406D9535-C16F-47FE-A7A4-029681A8F61D @default.
- Q91895948 P2093 Q91895948-0247E77A-DD6E-43EB-B8AC-95F4D076726A @default.
- Q91895948 P2093 Q91895948-174D7306-C6FB-4158-B645-48EAC7B5BF5D @default.
- Q91895948 P2093 Q91895948-2DC14EB8-7B6E-4D07-B2C3-37528361D250 @default.
- Q91895948 P2093 Q91895948-4CF7371A-1E76-4B08-B6EE-736CEFFA8862 @default.
- Q91895948 P2093 Q91895948-63CB7EC1-D0BA-430E-AE6D-CFC2931A8A0F @default.
- Q91895948 P2093 Q91895948-75DF7D08-FF48-4421-89A1-D53C6623DA72 @default.
- Q91895948 P2093 Q91895948-80E59F5E-4F43-4776-8A50-CCC36FC28E67 @default.
- Q91895948 P2093 Q91895948-DE9DE859-7B4B-4478-B615-76671BCC1FFC @default.
- Q91895948 P2093 Q91895948-EF8CA8C2-5555-4304-A6AF-22E098C734C8 @default.
- Q91895948 P2093 Q91895948-F54C0AE1-B520-4F4D-AF40-7A0EAF2B3918 @default.
- Q91895948 P31 Q91895948-F23233DE-8EEF-49E6-BDC3-FC552D91E966 @default.
- Q91895948 P356 Q91895948-4E9A3F2F-64D4-4D2C-A339-C968BA9196EE @default.
- Q91895948 P577 Q91895948-37376C1C-511B-453C-9A66-5F96A90E6B61 @default.
- Q91895948 P698 Q91895948-10F0B054-4EE1-4634-B5B5-521E31340093 @default.
- Q91895948 P356 ACS.MOLPHARMACEUT.0C00060 @default.
- Q91895948 P698 32286841 @default.
- Q91895948 P1433 Q3011140 @default.
- Q91895948 P1476 "Preclinical evaluation of a high affinity sarcophagine-containing PSMA ligand for 64Cu/67Cu-based theranostics in prostate cancer" @default.
- Q91895948 P2093 "Alejandro Amor-Coarasa" @default.
- Q91895948 P2093 "Anastasia Nikolopoulou" @default.
- Q91895948 P2093 "Clarence Williams" @default.
- Q91895948 P2093 "David J Schlyer" @default.
- Q91895948 P2093 "James M Kelly" @default.
- Q91895948 P2093 "John W Babich" @default.
- Q91895948 P2093 "Nicholas A Zia" @default.
- Q91895948 P2093 "Paul S Donnelly" @default.
- Q91895948 P2093 "Shashikanth Ponnala" @default.
- Q91895948 P2093 "Stephen G DiMagno" @default.
- Q91895948 P31 Q13442814 @default.
- Q91895948 P356 "10.1021/ACS.MOLPHARMACEUT.0C00060" @default.
- Q91895948 P577 "2020-04-14T00:00:00Z" @default.
- Q91895948 P698 "32286841" @default.